Details of the Drug

General Information of Drug (ID: DMAP8MV)

Drug Name

Iron

Synonyms

Eisen; Feronate; Ferretts; Ferrousal; Ferrum; Hemocyte; Hierro; LOHA; PZhO; Remko; Siderol; Yieronia; Ancor B; Armco iron; Carbonyl iron; Ferrous iron; Ferrovac E; Hoeganaes EH; Iron monocation; Iron standard for AAS; ATW 230; ATW 432; Atomel 28; Atomel 300M200; Atomel 500M; Atomel 95; Atomiron 44MR; Atomiron 5M; Atomiron AFP 25; Atomiron AFP 5; DSP 1000; DSP 128B; DSP 135; DSP 135C; DSP 138; EF 1000; EF 250; EFV 250; GS 6; HS 4849; Hoeganaes ATW 230; NC 100; PZh1M1; PZh2M; PZh2M1; PZh2M2; PZh3; PZh3M; PZh4M; Ancoren 80/150; Copy Powder CS 105-175; Diseases, iron overload; EFV 200/300; EFV 250/400; F 60 (metal); FT 3 (element); Fe-40; Fe1+; Ferro-Caps; Ferro-Time; HF 2 (element); HL (iron); HQ (metal); HS (iron); Iron (Fe); Iron(III) nitrate solution; Iron, elemental; PZh-1M3; PZh-2; SUY-B 2; Vitedyn-Slo; Diseases (animal), iron overload; Ed-In-Sol; Iron (Fe1+); Iron ion (Fe+); Iron ion(1+); Iron(1+); Iron(1+) ion; Iron, ion (Fe1+); Iron, ion (Fe1+) (8CI,9CI); 3ZhP

Indication

Disease Entry	ICD 11	Status	REF
Anemia of prematurity	N.A.	Approved	[1]
Folate-deficiency anemia	3A02.Y	Approved	[1]
Iron-deficiency anemia	3A00	Approved	[2]
------------------------------------------------------------------------------------

Therapeutic Class

Iron Supplement

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

#Ro5 Violations (Lipinski):
0

Molecular Weight

55.84

Logarithm of the Partition Coefficient

Not Available

Rotatable Bond Count

Hydrogen Bond Donor Count

Hydrogen Bond Acceptor Count

Chemical Identifiers

Formula: Fe
IUPAC Name: iron
Canonical SMILES: [Fe]
InChI: InChI=1S/Fe
InChIKey: XEEYBQQBJWHFJM-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 23925
ChEBI ID: CHEBI:18248
CAS Number: 7439-89-6
DrugBank ID: DB01592
TTD ID: D0Y3TM
VARIDT ID: DR00317
INTEDE ID: DR0882

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Hemoglobin (HB)	TTQO71U	HBA_HUMAN	Activator	[3]

------------------------------------------------------------------------------------

Drug Transporter (DTP)

DTP Name	DTP ID	UniProt ID	MOA	REF
Sodium/bile acid cotransporter 7 (SLC10A7)	DTG1RJO	NTCP7_HUMAN	Substrate	[4]
Natural resistance-associated macrophage protein 2 (SLC11A2)	DTVKMHD	NRAM2_HUMAN	Substrate	[5]

------------------------------------------------------------------------------------

Drug-Metabolizing Enzyme (DME)

DME Name	DME ID	UniProt ID	MOA	REF
Friedreich ataxia protein (FXN)_{Main DME}	DEXVHDB	FRDA_HUMAN	Substrate	[6]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

Drug-Drug Interaction (DDI) Information of This Drug

Coadministration of a Drug Treating the Disease Different from Iron (Comorbidity)

DDI Drug Name	DDI Drug ID	Severity	Mechanism	Comorbidity	REF
Sarecycline	DMLZNIQ	Moderate	Decreased absorption of Iron due to formation of complexes caused by Sarecycline .	Acne vulgaris [ED80]	[7]
ABT-492	DMJFD2I	Moderate	Decreased absorption of Iron due to formation of complexes caused by ABT-492.	Bacterial infection [1A00-1C4Z]	[8]
Omadacycline	DMR2J95	Moderate	Decreased absorption of Iron due to formation of complexes caused by Omadacycline.	Bacterial infection [1A00-1C4Z]	[7]
Dexlansoprazole	DM1DBV5	Moderate	Decreased absorption of Iron due to altered gastric pH caused by Dexlansoprazole.	Gastro-oesophageal reflux disease [DA22]	[9]
Dolutegravir	DMCZGRE	Major	Decreased absorption of Iron due to formation of complexes caused by Dolutegravir.	Human immunodeficiency virus disease [1C60-1C62]	[10]
Trientine	DMD2WPG	Moderate	Decreased absorption of Iron due to formation of complexes caused by Trientine.	Inborn metabolism deficiency [5C50-5C59]	[11]
Baloxavir marboxil	DM1UV7F	Moderate	Decreased absorption of Iron due to formation of complexes caused by Baloxavir marboxil.	Influenza [1E30-1E32]	[12]
Lanthanum carbonate	DMMJQSH	Moderate	Decreased absorption of Iron due to formation of complexes caused by Lanthanum carbonate.	Mineral absorption/transport disorder [5C64]	[13]
Eltrombopag	DMOGFIX	Moderate	Decreased absorption of Iron due to formation of complexes caused by Eltrombopag.	Thrombocytopenia [3B64]	[14]
-----------


⏷ Show the Full List of 9 DDI Information of This Drug

References

1	Iron FDA Label
2	Drug information of Iron, 2008. eduDrugs.
3	Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy. J Coll Physicians Surg Pak. 2008 Jul;18(7):424-7.
4	Modulation of macrophage iron transport by Nramp1 (Slc11a1). Immunobiology. 2007;212(9-10):751-7.
5	Transmembrane topology of the mammalian Slc11a2 iron transporter. Biochemistry. 2009 Sep 8;48(35):8422-34.
6	Iron dysregulation in Friedreich ataxia. Semin Pediatr Neurol. 2006 Sep;13(3):166-75.
7	Campbell NR, Hasinoff BB "Iron supplements: a common cause of drug interactions." Br J Clin Pharmacol 31 (1991): 251-5. [PMID: 2054263]
8	Nix DE, Wilton JH, Ronald B, Distlerath L, Williams VC, Norman A "Inhibition of norfloxacin absorption by antacids." Antimicrob Agents Chemother 34 (1990): 432-5. [PMID: 2334155]
9	Hutchison C, Geissler CA, Powell JJ, Bomford A "Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis." Gut 56 (2007): 1291-5. [PMID: 17344278]
10	Product Information. Tivicay (dolutegravir). ViiV Healthcare, Research Triangle Park, NC.
11	Product Information. Syprine (trientine). Aton Pharma, Lawrenceville, NJ.
12	Cerner Multum, Inc. "Australian Product Information.".
13	Canadian Pharmacists Association.
14	Cerner Multum, Inc. "UK Summary of Product Characteristics.".